• SPX
  • $5,928.43
  • 0.19 %
  • $11.32
  • DJI
  • $43,783.05
  • 0.86 %
  • $374.57
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,147.85
  • 0.78 %
  • $62.78
  • IXIC
  • $18,881.14
  • -0.45 %
  • -$85.01
CytomX Therapeutics, Inc. (CTMX) Insider Traders

CytomX Therapeutics, Inc. (CTMX) Insider Traders

NASDAQ Currency in USD Disclaimer

Stock Price

$0.85

-$0.02

(-2.25%)

Day's range
$0.84
Day's range
$0.87
  • NUMBER OF INSIDER BUYING

    (Last 12 Months)

    0
  • NUMBER OF INSIDER SELLING

    (Last 12 Months)

    5
  • AMOUNT OF INSIDERS BUYING

    (Last 12 Months)

    $0
  • AMOUNT OF INSIDERS SELLING

    (Last 12 Months)

    $138,069

CytomX Therapeutics, Inc. Insider Transactions

CytomX Therapeutics, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
ROWLAND LLOYD A

General Counsel

Sell 5,268 @ $2.09 $10,986 117,728 03/19/2024 03/21/2024
Sell 20,223 @ $2.09 $42,175 524,481 03/19/2024 03/21/2024
Ogden Christopher

SVP, Finance and Accounting

Sell 2,971 @ $2.09 $6,196 85,686 03/19/2024 03/21/2024
BELVIN MARCIA

SVP, Chief Scientific Officer

Sell 12,795 @ $2.09 $26,684 168,579 03/19/2024 03/21/2024
Landau Jeffrey B

Chief Business Officer

Sell 6,562 @ $2.09 $13,685 110,060 03/19/2024 03/21/2024
Sell 13,551 @ $1.38 $18,710 454,704 12/20/2023 12/22/2023
BELVIN MARCIA

SVP, Chief Scientific Officer

Sell 4,077 @ $1.38 $5,628 155,124 12/20/2023 12/22/2023
Landau Jeffrey B

Chief Business Officer

Sell 4,077 @ $1.38 $5,628 86,622 12/20/2023 12/22/2023
ROWLAND LLOYD A

General Counsel

Sell 4,077 @ $1.38 $5,629 97,996 12/20/2023 12/22/2023
Ogden Christopher

SVP, Finance and Accounting

Sell 1,990 @ $1.38 $2,747 48,657 12/20/2023 12/22/2023
BELVIN MARCIA

SVP, Chief Scientific Officer

Sell 4,119 @ $1.30 $5,356 147,951 09/22/2023 09/22/2023
Landau Jeffrey B

Chief Business Officer

Sell 4,119 @ $1.30 $5,356 76,379 09/22/2023 09/22/2023
Sell 14,601 @ $1.30 $18,987 430,755 09/22/2023 09/22/2023
ROWLAND LLOYD A

General Counsel

Sell 5,486 @ $1.30 $7,135 80,609 09/22/2023 09/22/2023
Jones Elaine V

Director

Buy 5,000 @ $1.55 $7,750 5,142 03/29/2023 03/31/2023
Ogden Christopher

SVP, Finance and Accounting

Sell 516 @ $1.98 $1,021 37,772 03/16/2023 03/20/2023
Sell 7,121 @ $1.88 $13,391 388,821 03/16/2023 03/20/2023
Sell 1,748 @ $1.98 $3,459 38,224 03/16/2023 03/20/2023
ROWLAND LLOYD A

General Counsel

Sell 2,037 @ $1.98 $4,031 71,095 03/16/2023 03/20/2023
Sell 1,477 @ $1.98 $2,923 69,248 03/16/2023 03/20/2023

CytomX Therapeutics, Inc. Frequently Asked Questions

  • Who is on CytomX Therapeutics, Inc.'s Insider Roster?

    The list of insiders at CytomX Therapeutics, Inc. includes Ogden Christopher, ROWLAND LLOYD A, Landau Jeffrey B, BELVIN MARCIA, McCarthy Sean A..

  • How much insider selling is happening at CytomX Therapeutics, Inc.?

    Insiders have sold a total of 75,591 CytomX Therapeutics, Inc. shares in the last 12 months for a total of 138,069 sold.

  • Which CytomX Therapeutics, Inc. insiders have been selling company stock?

    The following insiders have sold CytomX Therapeutics, Inc. shares in the last 12 months: Ogden Christopher ($8,943), ROWLAND LLOYD A ($16,616), Landau Jeffrey B ($19,313), BELVIN MARCIA ($32,312), McCarthy Sean A. ($60,885),

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.